Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis

<div>Forest plots of (a) immune cell and (b) tumour cell PD-L1 status with cut-off values of 5% and 1% in predicting the response to anti-PD-1/PD-L1 immunotherapy. PD-L1: programmed death-ligand 1; ORR: objective response rate; IC: immune cell; CI: confidence interval; M-H: Mantel-Hansel; SD: standard deviation.</div>

Disease Markers

fig5

Figure 5

Figure 5: Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis 

Figure 5 | Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis 